- Home
- MDXH vs BMN Comparison
MDXH vs BMN Comparison
Compare MDXH & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- BMN
- Stock Information
- Founded
- MDXH 2003
- BMN 2020
- Country
- MDXH Belgium
- BMN United States
- Employees
- MDXH N/A
- BMN 19800
- Industry
- MDXH
- BMN Trusts Except Educational Religious and Charitable
- Sector
- MDXH
- BMN Finance
- Exchange
- MDXH Nasdaq
- BMN Nasdaq
- Market Cap
- MDXH 141.1M
- BMN 150.8M
- IPO Year
- MDXH 2021
- BMN N/A
- Fundamental
- Price
- MDXH $3.90
- BMN $24.94
- Analyst Decision
- MDXH Buy
- BMN
- Analyst Count
- MDXH 1
- BMN 0
- Target Price
- MDXH $6.00
- BMN N/A
- AVG Volume (30 Days)
- MDXH 163.1K
- BMN 29.9K
- Earning Date
- MDXH 11-05-2025
- BMN 01-01-0001
- Dividend Yield
- MDXH N/A
- BMN 4.66%
- EPS Growth
- MDXH N/A
- BMN N/A
- EPS
- MDXH N/A
- BMN N/A
- Revenue
- MDXH $98,953,000.00
- BMN N/A
- Revenue This Year
- MDXH $24.77
- BMN N/A
- Revenue Next Year
- MDXH $22.21
- BMN N/A
- P/E Ratio
- MDXH N/A
- BMN N/A
- Revenue Growth
- MDXH 22.56
- BMN N/A
- 52 Week Low
- MDXH $1.35
- BMN $21.51
- 52 Week High
- MDXH $3.91
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- MDXH 68.73
- BMN 57.28
- Support Level
- MDXH $3.46
- BMN $24.60
- Resistance Level
- MDXH $3.80
- BMN $25.14
- Average True Range (ATR)
- MDXH 0.17
- BMN 0.33
- MACD
- MDXH -0.01
- BMN 0.04
- Stochastic Oscillator
- MDXH 94.74
- BMN 74.18
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.